Literature DB >> 1407471

Positron emission tomography-guided stereotactic brain biopsy.

M Levivier1, S Goldman, L M Bidaut, A Luxen, E Stanus, S Przedborski, D Balériaux, J Hildebrand, J Brotchi.   

Abstract

We describe a technique that allows target definition for stereotactic brain biopsy using coordinates calculated on stereotactic positron emission tomographic (PET) images. In this study, PET images were obtained using [18F]-labeled fluorodeoxyglucose, a marker for glucose metabolism. The difference between PET-calculated and actual stereotactic coordinates of simulated targets is within PET spatial resolution. Combined computed tomography- and PET-guided stereotactic biopsies were performed in 11 patients with brain tumors. In this report, we describe two representative patients who underwent stereotactic brain biopsy using the present technique. Because of the complementary role of PET and computed tomography, their integration in multimodality planning might optimize the target selection for stereotactic brain biopsies.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1407471     DOI: 10.1227/00006123-199210000-00029

Source DB:  PubMed          Journal:  Neurosurgery        ISSN: 0148-396X            Impact factor:   4.654


  9 in total

Review 1.  Positron emission tomography and the central nervous system.

Authors:  R O Robinson; C D Ferrie; M Capra; M N Maisey
Journal:  Arch Dis Child       Date:  1999-09       Impact factor: 3.791

2.  Glucocorticoid-induced long-term remission in primary cerebral lymphoma: case report and review of the literature.

Authors:  B Pirotte; M Levivier; S Goldman; J M Brucher; J Brotchi; J Hildebrand
Journal:  J Neurooncol       Date:  1997-03       Impact factor: 4.130

3.  European Society for Stereotactic and Functional Neurosurgery. Milan, Italy, June 12-15, 1996. Abstracts.

Authors: 
Journal:  Acta Neurochir (Wien)       Date:  1996       Impact factor: 2.216

Review 4.  PET Molecular Imaging-Directed Biopsy: A Review.

Authors:  Baowei Fei; David M Schuster
Journal:  AJR Am J Roentgenol       Date:  2017-05-15       Impact factor: 3.959

Review 5.  Oncological applications of positron emission tomography with fluorine-18 fluorodeoxyglucose.

Authors:  P Rigo; P Paulus; B J Kaschten; R Hustinx; T Bury; G Jerusalem; T Benoit; J Foidart-Willems
Journal:  Eur J Nucl Med       Date:  1996-12

6.  FDG-PET as a prognostic factor in high-grade astrocytoma.

Authors:  O De Witte; F Lefranc; M Levivier; I Salmon; J Brotchi; S Goldman
Journal:  J Neurooncol       Date:  2000-09       Impact factor: 4.130

7.  Use of positron emission tomography (PET) in stereotactic conditions for brain biopsy.

Authors:  B Pirotte; S Goldman; L M Bidaut; A Luxen; E Stanus; J M Brucher; D Balériaux; J Brotchi; M Levivier
Journal:  Acta Neurochir (Wien)       Date:  1995       Impact factor: 2.216

8.  11C-methionine PET for the diagnosis and management of recurrent pituitary adenomas.

Authors:  B N T Tang; M Levivier; M Heureux; D Wikler; N Massager; D Devriendt; P David; N Dumarey; B Corvilain; S Goldman
Journal:  Eur J Nucl Med Mol Imaging       Date:  2005-10-15       Impact factor: 9.236

9.  PET imaging in the surgical management of pediatric brain tumors.

Authors:  Benoit Pirotte; Francesco Acerbi; Alphonse Lubansu; Serge Goldman; Jacques Brotchi; Marc Levivier
Journal:  Childs Nerv Syst       Date:  2007-03-14       Impact factor: 1.532

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.